Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.

被引：2
|
作者：
Mateen, Abdul
Adil, Allah Rakha
Maken, Rab Nawaz
Hashmi, Quratul Ain
Abdullah, Famya
Duraishi, Arif Moin
机构：
[1] MINAR Canc Hosp, Dept Radiotherapy & Oncol, Multan, Pakistan
[2] MINAR Canc Hosp, Multan, Pakistan
[3] INMOL Canc Hosp, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12511
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ROLE OF CISPLATIN AND DOXORUBICIN AS NEOADJUVANT IN LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Athar, Azka
    BREAST, 2018, 41 : S21 - S21
  • [2] Neoadjuvant cisplatin and doxorubicin in locally advanced breast cancer
    Gurchani, S. A.
    Masood, A. I.
    Anwer, A.
    Mateen, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Efficacy of neoadjuvant cisplatin and oral capecitabine in locally advanced triple-negative breast cancer
    Latif, N.
    Rana, F. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer
    不详
    BREAST, 2005, 14 : S42 - S42
  • [5] Induction chemotherapy for patients with Locally advanced triple negative breast cancer.
    Ignatova, Ekaterina
    Frolova, Mona
    Stenina, Marina B.
    Petrovsky, Alexander
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] NEOADJUVANT PLATINUM CONTAINING REGIMEN FOR LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Rahal, M. M.
    Ramadan, H.
    Hassan, E.
    Arini, A.
    Mosleh, H.
    Al Naimy, N.
    Senan, E.
    Abdelwarith, A.
    Al Faraj, A.
    Halawani, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 114 - 115
  • [8] Primary chemotherapy with doxorubicin followed by docetaxel-cisplatin in locally advanced breast cancer.
    Ezzat, A
    Rahal, M
    Twegieri, T
    Akhtar, S
    Al Sayed, A
    Ajarim, D
    Tulbah, A
    Al Malik, O
    Al Shabanah, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 52S - 52S
  • [9] Preliminary results of a prospective pilot study of cisplatin (C) and doxorubicin (D) as neoadjuvant chemotherapy (NACT) for locally advanced triple-negative breast cancer (TNBC)
    Zhukova, Lyudmila
    Okruzhnova, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Cancer-testis antigens in triple-negative and locally advanced breast cancer.
    Harris, Samuel John
    Turner, Natalie Heather
    Chionh, Fiona J. M.
    Walkiewicz, Marzena
    Chakrabarti, Anannya
    Deb, Siddhartha
    Cebon, Jonathan S.
    White, Shane
    John, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345